Thyas provides preparations of regenerative immunocell therapy for cancer and infection.
Thyas Co. Ltd. provides preparations of regenerative immunocell therapy for cancer and infection.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 20, 2019 | Series Unknown | ¥240M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Chuo Shinkin Venture Capital | — | Series Unknown |